vs
Side-by-side financial comparison of SOUTHERN COPPER CORP (SCCO) and Zoetis (ZTS). Click either name above to swap in a different company.
SOUTHERN COPPER CORP is the larger business by last-quarter revenue ($3.9B vs $2.4B, roughly 1.6× Zoetis). SOUTHERN COPPER CORP runs the higher net margin — 33.9% vs 25.3%, a 8.6% gap on every dollar of revenue. On growth, SOUTHERN COPPER CORP posted the faster year-over-year revenue change (39.0% vs 3.0%). SOUTHERN COPPER CORP produced more free cash flow last quarter ($1.1B vs $732.0M). Over the past eight quarters, SOUTHERN COPPER CORP's revenue compounded faster (22.0% CAGR vs 4.4%).
Southern Copper Corporation, organized in Delaware and headquartered in Phoenix, Arizona, owns copper mines, smelters, and refineries in Peru and Mexico, including the Cuajone mine, the Toquepala mine, and the Tia Maria mine in Peru and the Buenavista mine and the La Caridad Mine in Mexico. In 2024, the company mined 2.1 billion pounds of copper, 21 million ounces of silver, 64 million pounds of molybdenum, and 286 million pounds of zinc.
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
SCCO vs ZTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9B | $2.4B |
| Net Profit | $1.3B | $603.0M |
| Gross Margin | 62.0% | 70.2% |
| Operating Margin | 54.5% | 31.9% |
| Net Margin | 33.9% | 25.3% |
| Revenue YoY | 39.0% | 3.0% |
| Net Profit YoY | 64.7% | 3.8% |
| EPS (diluted) | $1.49 | $1.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9B | $2.4B | ||
| Q3 25 | $3.4B | $2.4B | ||
| Q2 25 | $3.1B | $2.5B | ||
| Q1 25 | $3.1B | $2.2B | ||
| Q4 24 | $2.8B | $2.3B | ||
| Q3 24 | $2.9B | $2.4B | ||
| Q2 24 | $3.1B | $2.4B | ||
| Q1 24 | $2.6B | $2.2B |
| Q4 25 | $1.3B | $603.0M | ||
| Q3 25 | $1.1B | $721.0M | ||
| Q2 25 | $976.7M | $718.0M | ||
| Q1 25 | $949.1M | $631.0M | ||
| Q4 24 | $796.2M | $581.0M | ||
| Q3 24 | $899.8M | $682.0M | ||
| Q2 24 | $953.8M | $624.0M | ||
| Q1 24 | $738.8M | $599.0M |
| Q4 25 | 62.0% | 70.2% | ||
| Q3 25 | 59.8% | 71.5% | ||
| Q2 25 | 60.3% | 73.6% | ||
| Q1 25 | 57.7% | 72.0% | ||
| Q4 24 | 56.5% | 69.5% | ||
| Q3 24 | 58.3% | 70.6% | ||
| Q2 24 | 59.9% | 71.7% | ||
| Q1 24 | 55.5% | 70.6% |
| Q4 25 | 54.5% | 31.9% | ||
| Q3 25 | 52.4% | 37.0% | ||
| Q2 25 | 52.0% | 36.7% | ||
| Q1 25 | 49.2% | 36.5% | ||
| Q4 24 | 47.0% | 31.6% | ||
| Q3 24 | 49.5% | 36.6% | ||
| Q2 24 | 51.5% | 33.0% | ||
| Q1 24 | 45.8% | 34.1% |
| Q4 25 | 33.9% | 25.3% | ||
| Q3 25 | 32.9% | 30.0% | ||
| Q2 25 | 32.0% | 29.2% | ||
| Q1 25 | 30.4% | 28.4% | ||
| Q4 24 | 28.6% | 25.1% | ||
| Q3 24 | 30.7% | 28.6% | ||
| Q2 24 | 30.6% | 26.4% | ||
| Q1 24 | 28.4% | 27.4% |
| Q4 25 | $1.49 | $1.37 | ||
| Q3 25 | $1.35 | $1.63 | ||
| Q2 25 | $1.21 | $1.61 | ||
| Q1 25 | $1.19 | $1.41 | ||
| Q4 24 | $1.02 | $1.29 | ||
| Q3 24 | $1.15 | $1.50 | ||
| Q2 24 | $1.22 | $1.37 | ||
| Q1 24 | $0.95 | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9B | — |
| Total DebtLower is stronger | $6.8B | — |
| Stockholders' EquityBook value | $11.0B | $3.3B |
| Total Assets | $21.4B | $15.5B |
| Debt / EquityLower = less leverage | 0.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9B | — | ||
| Q3 25 | $4.5B | $2.1B | ||
| Q2 25 | $4.0B | $1.4B | ||
| Q1 25 | $4.3B | $1.7B | ||
| Q4 24 | $3.5B | $2.0B | ||
| Q3 24 | $3.0B | $1.7B | ||
| Q2 24 | $2.2B | $1.6B | ||
| Q1 24 | $1.6B | $2.0B |
| Q4 25 | $6.8B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $6.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $6.3B | — | ||
| Q1 24 | $6.3B | — |
| Q4 25 | $11.0B | $3.3B | ||
| Q3 25 | $10.4B | $5.4B | ||
| Q2 25 | $10.0B | $5.0B | ||
| Q1 25 | $9.6B | $4.7B | ||
| Q4 24 | $9.2B | $4.8B | ||
| Q3 24 | $8.9B | $5.2B | ||
| Q2 24 | $8.5B | $5.0B | ||
| Q1 24 | $7.5B | $5.1B |
| Q4 25 | $21.4B | $15.5B | ||
| Q3 25 | $20.3B | $15.2B | ||
| Q2 25 | $19.6B | $14.5B | ||
| Q1 25 | $19.8B | $14.1B | ||
| Q4 24 | $18.7B | $14.2B | ||
| Q3 24 | $18.4B | $14.4B | ||
| Q2 24 | $17.8B | $14.2B | ||
| Q1 24 | $16.8B | $14.3B |
| Q4 25 | 0.61× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.74× | — | ||
| Q1 24 | 0.83× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.5B | $893.0M |
| Free Cash FlowOCF − Capex | $1.1B | $732.0M |
| FCF MarginFCF / Revenue | 27.7% | 30.7% |
| Capex IntensityCapex / Revenue | 10.9% | 6.7% |
| Cash ConversionOCF / Net Profit | 1.14× | 1.48× |
| TTM Free Cash FlowTrailing 4 quarters | $3.4B | $2.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5B | $893.0M | ||
| Q3 25 | $1.6B | $938.0M | ||
| Q2 25 | $976.8M | $486.0M | ||
| Q1 25 | $721.4M | $587.0M | ||
| Q4 24 | $1.4B | $905.0M | ||
| Q3 24 | $1.4B | $951.0M | ||
| Q2 24 | $962.1M | $502.0M | ||
| Q1 24 | $659.7M | $595.0M |
| Q4 25 | $1.1B | $732.0M | ||
| Q3 25 | $1.2B | $805.0M | ||
| Q2 25 | $741.1M | $308.0M | ||
| Q1 25 | $403.6M | $438.0M | ||
| Q4 24 | $1.1B | $689.0M | ||
| Q3 24 | $1.2B | $784.0M | ||
| Q2 24 | $630.3M | $370.0M | ||
| Q1 24 | $445.9M | $455.0M |
| Q4 25 | 27.7% | 30.7% | ||
| Q3 25 | 35.8% | 33.5% | ||
| Q2 25 | 24.3% | 12.5% | ||
| Q1 25 | 12.9% | 19.7% | ||
| Q4 24 | 40.4% | 29.7% | ||
| Q3 24 | 40.7% | 32.8% | ||
| Q2 24 | 20.2% | 15.7% | ||
| Q1 24 | 17.2% | 20.8% |
| Q4 25 | 10.9% | 6.7% | ||
| Q3 25 | 10.3% | 5.5% | ||
| Q2 25 | 7.7% | 7.2% | ||
| Q1 25 | 10.2% | 6.7% | ||
| Q4 24 | 8.5% | 9.3% | ||
| Q3 24 | 8.4% | 7.0% | ||
| Q2 24 | 10.6% | 5.6% | ||
| Q1 24 | 8.2% | 6.4% |
| Q4 25 | 1.14× | 1.48× | ||
| Q3 25 | 1.40× | 1.30× | ||
| Q2 25 | 1.00× | 0.68× | ||
| Q1 25 | 0.76× | 0.93× | ||
| Q4 24 | 1.71× | 1.56× | ||
| Q3 24 | 1.60× | 1.39× | ||
| Q2 24 | 1.01× | 0.80× | ||
| Q1 24 | 0.89× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SCCO
| Other | $1.3B | 32% |
| MX | $726.4M | 19% |
| CH | $560.4M | 14% |
| PE | $218.8M | 6% |
| Silver | $201.1M | 5% |
| BR | $157.9M | 4% |
| CL | $149.0M | 4% |
| Molybdenum | $143.3M | 4% |
| ES | $130.8M | 3% |
| Mexican IMMSA Unit | $129.8M | 3% |
| IT | $107.1M | 3% |
| Zinc | $88.8M | 2% |
ZTS
| Other | $1.3B | 56% |
| Livestock | $234.0M | 10% |
| Pain Sedation | $209.0M | 9% |
| Other Pharmaceuticals | $188.0M | 8% |
| Swine | $125.0M | 5% |
| Poultry | $117.0M | 5% |
| Fish | $81.0M | 3% |
| Other Non Pharmaceuticals | $70.0M | 3% |
| Manufactured Product Other | $18.0M | 1% |
| Medicated Feed Additives | $12.0M | 1% |
